In This Article:
The market has been flat over the last week but is up 6.7% over the past year, with earnings forecast to grow by 15% annually. In such a dynamic environment, identifying high-growth tech stocks like Craneware and two other promising companies can offer significant opportunities for investors seeking robust returns.
Top 10 High Growth Tech Companies In The United Kingdom
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
STV Group | 13.15% | 46.78% | ★★★★★☆ |
Gaming Realms | 11.57% | 22.07% | ★★★★★☆ |
YouGov | 14.29% | 29.79% | ★★★★★☆ |
Facilities by ADF | 52.00% | 144.70% | ★★★★★☆ |
Redcentric | 4.89% | 63.79% | ★★★★★☆ |
Windar Photonics | 67.08% | 130.82% | ★★★★★☆ |
LungLife AI | 100.61% | 100.97% | ★★★★★☆ |
IQGeo Group | 11.49% | 63.61% | ★★★★★☆ |
Beeks Financial Cloud Group | 24.63% | 57.95% | ★★★★★☆ |
Vinanz | 113.60% | 125.86% | ★★★★★☆ |
Click here to see the full list of 47 stocks from our UK High Growth Tech and AI Stocks screener.
Let's explore several standout options from the results in the screener.
Craneware
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Craneware plc, with a market cap of £803.93 million, develops, licenses, and supports computer software for the healthcare industry in the United States.
Operations: Craneware plc generates revenue primarily through its healthcare software segment, which reported $189.27 million. The company focuses on developing, licensing, and supporting computer software tailored for the U.S. healthcare industry.
Craneware, a UK-based tech firm, showcases robust growth with a reported 8.2% annual revenue increase and an impressive 25.6% forecast in earnings growth, outpacing the UK market's average. This financial vigor is complemented by strategic expansions through acquisitions aimed at enhancing data capabilities and broadening the U.S. hospital market reach. Notably, its collaboration with Microsoft leverages Azure's cloud solutions to innovate healthcare applications, ensuring Craneware remains pivotal in transforming healthcare efficiency and data analytics. These initiatives underscore its commitment to maintaining a competitive edge through continuous innovation and strategic market positioning.
-
Click here to discover the nuances of Craneware with our detailed analytical health report.
-
Evaluate Craneware's historical performance by accessing our past performance report.
GB Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: GB Group plc, with a market cap of £799.20 million, offers identity data intelligence products and services across the United Kingdom, the United States, Australia, and internationally.
Operations: The company generates revenue through three primary segments: Fraud (£40.20 million), Identity (£156.06 million), and Location (£81.07 million). The Identity segment is the largest contributor to its revenue stream.